Noteworthy, in MDA5+ DM patients a specific subtype of CD14+ monocytes strongly expressing IFI27, a biomarker reported for mild early Sars-CoV-2 infection, has been discovered (41, 58). This evidence concerns the gene CD14 and dermatomyositis.